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Abstract
 
Osteopontin (OPN) is a chemotactic protein that attracts immune cells, to inflammatory sites.
The sensitization phase of allergic cutaneous contact hypersensitivity (CHS) requires the migra-
tion of Langerhans cells/dendritic cells (LCs/DCs) from skin to draining lymph nodes. Charac-
terizing OPN function for LC/DC migration we found upregulated OPN expression in hap-
ten sensitized skin and draining lymph nodes. OPN induces chemotactic LC/DC migration,
initiates their emigration from the epidermis, and attracts LCs/DCs to draining lymph nodes by
interacting with CD44 and 
 
 
 
v integrin. Furthermore, OPN-deficient mice have a significantly
reduced CHS response that correlates with an impaired ability of OPN-deficient mice to at-
tract LCs/DCs to draining lymph nodes. In conclusion, OPN is an important factor in the ini-
tiation of CHS by guiding LCs/DCs from skin into lymphatic organs.
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Introduction
 
Dendritic cells (DCs)
 
*
 
 are a special subset of potent anti-
gen-presenting cells that are central in the induction of cel-
lular immune reactions against various antigens, among
them infectious agents, tumor associated antigens, foreign
proteins, and chemical haptens (for reviews, see references
1–3). Immature cells of the DC lineage are situated in non-
lymphoid tissues of many organs (2). For example Langer-
hans cells (LCs), the DCs of the epidermis, are situated in
the suprabasal layers of the epidermis (2, 4). Upon antigenic
stimulation in the presence of inflammatory mediators
these LCs/DCs mature, process antigen, and become mi-
gratory (for a review, see references 1–3). They enter sec-
ondary lymphoid organs where they use these newly ac-
quired capabilities to induce T cell–dependent immune
responses (1, 3, 5). Although a variety of factors involved
have been characterized, migration of LCs/DCs between
peripheral organs such as the skin and secondary lymphatic
tissues is only beginning to be understood. However, firm
knowledge of the DC migratory process is essential for
clinical application of DCs in tumor and antimicrobial vac-
cination protocols or for the attenuation of allergic re-
sponses. Easy accessibility of epidermal LCs has made the
skin the preferred organ to study DC migration in different
models (2, 6, 7).
Osteopontin (OPN) is a secreted acidic phosphoprotein
with functions in bone remodeling, tumor metastasis, and
host defense (8, 9). A variety of immunological disorders
were shown to be associated with high OPN expression,
e.g., by activated lymphocytes and macrophages (10–13).
Initially, OPN (eta1) was found to be expressed after non-
specific activation in T cells and a subset of natural killer cells
(11, 13). In murine immune deficiency syndrome (MIDS),
elevated levels of OPN were detected in spleens and lymph
nodes of infected animals (10). Interestingly, OPN is in-
volved in delayed type hypersensitivity reactions against 
 
My-
cobacterium tuberculosis 
 
and OPN is detectable in macro-
phages, lymphocytes, and the extracellular matrix (ECM) in
diseased tissue with granulomatous pathology (9, 14, 15).
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Osteopontin in DC Migration
 
Mice lacking OPN have an attenuated host resistance
against 
 
Mycobacterium bovis
 
 (16). Further, mice deficient in
OPN have a severely impaired cell-mediated immunity
against herpes simplex virus-type 1 or 
 
Listeria monocytogenes
 
and do not form sarcoid-type granulomas (17).
OPN may act in both a monomeric as well as in a poly-
meric form (18). The polymeric form interacts mainly with
ECM components like collagens (18, 19) and fibronectin
(18, 20). Thus, OPN exerts dual functions as a chemoat-
tractive cytokine and as an ECM component initiating
cell–ECM interactions. In its function as a cytokine, OPN
attracts monocytes to sites of inflammation, stimulates che-
motactic endothelial cell migration, and attracts smooth
muscle cells (14, 21, 22).
OPN, like fibronectin, contains a GRGDS integrin
binding domain thereby promoting adhesion of cells ex-
pressing 
 
 
 
v
 
 
 
3, 
 
 
 
v
 
 
 
1, and 
 
 
 
v
 
 
 
5 integrins (22). The 
 
 
 
v
 
 
 
3
integrin is particularly important for supporting OPN-
induced cell migration in smooth muscle cells and endothe-
lial cells (21, 22). CD44 has been characterized as another
receptor stimulating OPN-induced migration (23). OPN
stimulated cell migration in CD44-transfected A31 murine
fibroblasts and in pancreatic carcinoma cell lines transfected
with CD44 variants encoding CD44 isoforms (23, 24).
Our investigation was designed to functionally charac-
terize DC–OPN interactions focusing on two putative
OPN receptors that mediate OPN-induced cell migration,
CD44 and 
 
 
 
v
 
 
 
3. We have previously shown that CD44 is
differentially modulated during LC/DC activation and
participates in their migration out of the skin, their adhe-
sion to the paracortical T cell zones of peripheral lymph
nodes, and in the LC-dependent sensitization phase of
contact hypersensitivity (CHS) (25). However, the ligands
responsible for the described CD44 functions remained
uncharacterized.
Here we demonstrate that OPN is crucially involved in
DC migration from the skin to regional lymph nodes dur-
ing the sensitization phase of CHS. OPN interacts with
both CD44 and 
 
 
 
v on DC, thereby inducing chemotactic
DC migration. Further, we show that OPN-deficient mice
are compromised in their ability to attract LCs/DCs to
draining lymphatic organs and have an impaired CHS re-
sponse to Trinitro-chloro-benzene (TNCB).
 
Materials and Methods
 
Media and Chemicals
 
Complete-RPMI 1640 (c-RPMI; GIBCO BRL) was sup-
plemented with 10% heat-inactivated FCS (GIBCO BRL), 25
mM HEPES (Sigma-Aldrich), 1 mM nonessential amino acids
(GIBCO BRL), 2 mM L-glutamine (GIBCO BRL), 1 nM 2-mer-
captoethanol (Sigma-Aldrich), penicillin, and streptomycin, both
90 
 
 
 
g/liter (GIBCO BRL).
 
GST-Fusion Proteins
 
GST–OPN fusion proteins were synthesized based on the
published murine OPN cDNA sequence (26) as described previ-
ously (27).
 
OPN-null Mutant Mice
 
The mice lacking the functional OPN gene (spp1) were de-
scribed previously (28). Mice were crossed to the C57BL/6 back-
ground. For all experiments, OPN mutant mice and their wild-
type littermates in the sixth generation of backcrossing were used.
 
DC Cultures
 
Murine DCs were generated as described (29, 30), with minor
alterations. Bone marrow was harvested from the tibia and fibula
of C57BL/6 mice. The cells were resuspended at 10
 
6
 
 cells/ml
cRPMI-1640 (GIBCO BRL) with 40 ng/ml recombinant mu-
rine GM-CSF (PromoCell) and 10 ng/ml recombinant murine
IL-4 (PromoCell). Cells were cultured at 1-ml aliquots in 24-well
culture plates (Greiner). Cells were fed on days 3 and 5 of culture,
by replacing half the medium in each well with fresh cRPMI
containing GM-CSF and IL-4. Loosely adherent cells, including
DCs were harvested by gentle pipetting, on day 6 of culture.
Cells were washed once and resuspended at 5 
 
 
 
 10
 
5
 
 cells/ml in
cRPMI. 8 ml of the cell suspension were underlayed with 2 ml
14.5% Metrizamide (Boehringer) in a 14-ml conical bottomed
tube (Becton Dickinson) and centrifuged at room temperature
(22
 
 
 
C) for 20 min at 600 
 
g
 
. The low buoyant density cells were
collected, washed twice, and resuspended for use. These suspen-
sions that were used in all following experiments contained rou-
tinely 
 
 
 
80% cells expressing highly Iab, CD11c, B7–1, and B7–2
and were designated DCs (30).
 
Immunostaining and Flow Cytometry
 
Cells were stained as described (25) with one of the following
mAbs: murine-specific anti-
 
 
 
v (anti-CD51, clone H9.2B8, Arme-
nian hamster IgG, biotinylated; BD PharMingen), anti-
 
 
 
3 (CD61,
Clone 2C9.G2, Armenian hamster IgG, biotinylated; BD Phar-
Mingen), anti-CD44 (IM7, rat IgG, PE labeled), or appropriate
isotype control (clone 8C1, Armenian hamster IgG, biotinylated
labeled, or rat IgG [R3–34], PE labeled; all BD PharMingen). 7-ami-
noactinomycin D (7-ADD, 2.5 
 
 
 
g/ml; Sigma-Aldrich) was added
to exclude dead cells by appropriate gating. CELLQuest™ soft-
ware (Becton Dickinson) was applied using a FACScan™ (Becton
Dickinson) to analyze 10
 
4
 
 viable cells from each sample.
 
Full-thickness Skin Organ Culture
 
Skin cultures and immunohistochemical staining were per-
formed as described previously (25). In brief, 4-mm punch biop-
sies containing human dermis and epidermis were placed into 25-
mm tissue culture inserts with a 0.02-
 
 
 
m anapore membrane
(Nunc) and incubated in 6-well tissue culture plates filled with
C-RPMI up to the dermal-epidermal junction. Cultures were
terminated as indicated and samples shock-frozen in N
 
2
 
. Sections
(5 
 
 
 
m) were prepared with a Cryocut 1800 (Leica). First, sec-
tions were overlaid with mAb against OPN (10A16, mouse IgG,
Immunobiological Laboratory [31]) for 30 min, room tempera-
ture, followed by a Cy3-conjugated goat-F(ab)
 
2
 
-anti–mouse IgG
(H
 
 
 
L) antibody for 1 h, room temperature. In a second step,
sections were incubated with FITC-conjugated anti-CD1a mAb
for 30 min (room temperature). Serial sections of biopsies were
stained with hemalum to obtain bright field images. Staining was
evaluated with a ZEISS Axioskop, equipped with a MC100 cam-
era system.
 
In Vitro DC Migration Assay
 
In vitro DC migration was evaluated using a 48-well micro
chemotaxis chamber (Costar) as described previously (32). 27 
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l of chemoattractant at the indicated concentrations in HBSS
with or without Ca
 
2
 
 
 
, Mg
 
2
 
 
 
, were added to the lower cham-
ber. A polycarbonate-filter, pore size 8 
 
 
 
m (Costar) was lay-
ered onto the wells, covered by a silicon gasket followed by the
top plate. For migration of DCs, 50 
 
 
 
l of cell suspension (10
 
6
 
cells/ml HBSS without Ca
 
2
 
 
 
, Mg
 
2
 
 
 
) were added to the upper
chamber. After the incubation, at 37
 
 
 
C, 5% CO
 
2
 
 for 4 h, filters
were removed and stained with Diff-Quick (Baxter). Cells on
the upper filter surface were removed, cells that had migrated
to the filter bottom quantified counting four ocular grids
(40
 
 
 
). Results are expressed as mean number of migrated
cells/mm
 
2
 
 
 
 
 
 SD of four chambers. Each experiment was per-
formed in triplicate. For one set of experiments, filters were
coated with 100 
 
 
 
g/ml gelatine in 0.1% acetic acid at 37
 
 
 
C
overnight (Sigma-Aldrich). For mAb blocking experiments,
DCs were preincubated with the mAbs IM7 (murine pan
CD44, rat IgG2b; BD PharMingen), KM81 (murine pan
CD44, rat IgG2a, TIB-241; American Type Culture Collec-
tion), anti-RMV7 (against 
 
 
 
v integrin, rat IgG2c, supplied by
Drs. Yagita and Okumura, Juntendo University School of
Medicine, Tokyo, Japan [33]), or isotype control mAb Y13–
259 (rat IgG1; American Type Culture Collection) at 10 
 
 
 
g/
ml for 30 min at 37
 
 
 
C, 5% CO
 
2
 
.
 
In Vivo LC/DC Migration Assays
 
LC Migration in Ear Pinnae.
 
20 
 
 
 
l OPN (50 
 
 
 
g/ml in PBS)
were injected into the ear pinnae of mice. For blocking experi-
ments anti-CD44 mAb (IM7 or KM81) anti-
 
 
 
v integrin mAb
(RMV7) or isotype control mAb Y13–259 (rat IgG1; American
Type Culture Collection) were coinjected. After 48 h animals
were killed and ears were cut off at the base with scissors. Epi-
dermal sheets were prepared as described (34). In brief, ears were
spread out on a Petri dish, then split into dorsal and ventral
halves with forceps. The dorsal halves were treated with 0.5%
dispase (Boehringer) at 37
 
 
 
C for 1.5 h on a shaker. Epidermis
was split from dermis and epidermal sheets were washed with
PBS. After fixation in 4% formaldehyde with cacodylic acid
buffer epidermal sheets were stained by ATPase histochemistry
as described (34). The number of dark brown staining LCs in the
epidermis was evaluated by counting four high power grids. Re-
sults are shown as number of LC/mm
 
2
 
 
 
 
 
 SD in sheets from four
ears.
 
Analysis of Lymph Node DCs after FITC Skin Painting.
 
The
number of lymph node DCs after FITC skin painting was ana-
lyzed as described previously with minor alterations (35). In
brief, FITC (Sigma-Aldrich) was dissolved in a 50:50 (vol/vol)
acetone dibutylphtalate (BDH) mixture just before application.
Mice were painted on the shaved abdomen and thorax with 0.4
ml of 5 mg/ml of FITC. Inguinal and axillary lymph nodes of
one mouse were obtained after 48 h, mechanically disaggre-
gated, pooled, stained with an PE labeled mAb against mouse
CD11c (clone 8L3, hamster IgG; BD PharMingen), and FITC
double-positive cells were analyzed by a FACS
 
®
 
 (Becton Dick-
inson).
 
DC Migration in OPN Mutant Mice.
 
DCs were generated
form wild-type littermates of OPN mutant mice, labeled as de-
scribed above, and injected at 250,000 DCs in 30 
 
 
 
l of PBS into
each quadrant of the abdominal skin of wild-type or OPN mu-
tant mice. Inguinal and axillary lymph nodes were obtained after
20 h, mechanically disaggregated, pooled, stained with a PE-
labeled mAb against mouse CD11c (clone 8L3, hamster IgG; BD
PharMingen) and CD11c, PKH2-GL
 
®
 
 double-positive cells were
analyzed by a FACS
 
®
 
.
 
CHS Assays
 
6-wk-old female C57BL/6 OPN mutant mice or wild-type
littermates were painted on their abdominal skin with 100
 
 
 
l of
7% TNCB in acetone at day 0 (25). On day 5, mice were chal-
lenged by painting 10 
 
 
 
l 1% TNCB on both sides of the ears. Ear
thickness was measured with an engineer’s micrometer (Mitu-
toyo) before and at 24 and 48 h after the challenge and ear swell-
ing was calculated (25).
 
RNA Isolation, Reverse Transcription and PCR Amplification of 
Sensitized Skin and Skin Draining Lymph Nodes
 
Abdominal skin of C57BL/6 mice was painted with TNCB
(7%), or as a control with acetone, as described previously (25).
Mice were killed at 6, 12, 24, and 48 h after hapten application.
Skin specimens and regional draining inguinal lymph nodes
where obtained and immediately shock-frozen in liquid nitrogen,
for later analysis by reverse transcription (RT)-PCR. Total cellu-
lar RNA from skin specimens and lymph nodes was extracted us-
ing Total RNA Rneasy
 
®
 
 Kit according to the manufacturer’s
protocol (QIAGEN). OPN transcript-specific primers were syn-
thesized based on the published sequences for murine OPN (26):
OPN upper primer 5
 
 
 
-ATTTGCTTTTGCCTGTTTGG-3
 
 
 
(starting at position 
 
 
 
16 of the published cDNA of Craig et al.
[26]), OPN lower primer 5
 
 
 
-CCTTTCCGTTGTTGTCC-
TGA-3
 
 
 
 (position 
 
 
 
603). The PCR resulting in amplification of
a 606-bp fragment was performed at 94
 
 
 
C for 60 s, 50
 
 
 
C for 60 s,
and 72
 
 
 
C for 60 s for a total of 35 cycles. As a control, RT-PCR
experiments using murine 
 
 
 
-actin primers 5
 
 
 
-GACTACCTCA-
TGAAGATCCT-3
 
 
 
 (position 639 of the cDNA published pre-
viously (36) and 5
 
 
 
-ATCCACATCTGCTGGAAGGT-3
 
 
 
 (po-
sition 1,131) amplifying a 511-bp cDNA fragment were
performed (94
 
 
 
C for 60 s, 53
 
 
 
C for 60 s, and 72
 
 
 
C for 60 s for a
total of 25 cycles). Amplified fragments were separated in paral-
lel with the coamplified actin reference fragment by electro-
phoresis in 2% agarose (GIBCO). Fluorescence was visualized at
312 nm UV, digitalized with a high-resolution CCD camera
(Herolab), and the individual fragments were quantitated and
relative intensity was analyzed with the E.A.S.Y.
 
®
 
 Win32-soft-
ware (Herolab).
 
Immunohistochemistry of Skin Draining Lymph Nodes
 
Abdominal skin of C57BL/6 mice was painted with TNCB
(7%), or as a control with acetone, as described previously (25).
Mice were killed at 0, 24, and 48 h after hapten application. Re-
gional skin draining inguinal lymph nodes where obtained and
immediately shock-frozen in liquid nitrogen. Skin draining
lymph nodes were obtained after TNCB skin paining as de-
scribed above. Specimens were embedded in Optimum Cutting
Medium (Miles Inc.) and sections (5 
 
 
 
m) were prepared with a
Cryocut 1800 (Leica). Air-dried, acetone-fixed frozen sections
were stained for OPN using a four-step immunohistochemical
staining protocol (ABC-technique; Dako): (a) primary anti-OPN
mAb 2.2 (rat anti–mouse) (37); (b) biotin-conjugated rabbit anti–
rat IgG; (c) peroxides conjugated streptavidin, and (d) Dako
 
®
 
3-amino-9-ethyl carbazole (AEC) as chromogenic substrate. For
CD3 staining biotinylated anti-CD3 mAb (rat anti–mouse; Di-
anova) was used. Staining was visualized with VECTASTAIN
 
®
 
ABC-AP Kit (Vector Laboratories) using Vector Blue Substrate
Kit III (Vector Laboratories) as a chromogen. Control staining
was performed by replacing the primary antibody with isotype-
matched control reagents. Staining was evaluated with a ZEISS
Axioskop, equipped with a MC100 camera system. 
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Results
OPN Is Upregulated in the Sensitization Phase of CHS.
OPN has been shown to be a chemotactic factor that at-
tracts inflammatory cells, such as monocytes and T cells to
sites of inflammation (14, 17, 38, 39).
The sensitization phase of CHS crucially depends upon
the migration of LCs from the epidermis to lymph nodes
draining the skin. We speculated that OPN secreted e.g., by
other inflammatory cells or endothelial cells could function
to guide LCs from the epidermis to draining lymph nodes.
To explore the expression of OPN during migration of hu-
man LCs from the epidermis we made use of an explant
culture in which LCs move actively from the epidermis into
dermis (25). Skin cryostat sections were stained by immu-
nohistochemical double labeling using mAb against CD1a
or Lag mAb, specific for LCs (FITC, green) and OPN-spe-
cific mAb 10A16 (Cy3, red). At 24 h of skin culture OPN
was strongly expressed in the dermis in the area of the pap-
illary vascular plexus, most likely reflecting staining of der-
mal microvascular endothelial cells which highly express
OPN (21; Fig. 1 A–D). LCs were found to migrate pre-
dominantly toward sites of high OPN expression forming
cords in these areas (Fig. 1 B) as shown previously (25, 40).
Our explant model mimics the migration process of LCs
during the sensitization phase of allergic CHS. We there-
fore speculated that OPN is upregulated in skin during the
sensitization phase of CHS. To test this hypothesis, the
hapten TNCB was applied to the abdominal skin of
C57BL/6 mice. Hapten painted abdominal skin, the re-
gional skin draining axillary lymph nodes, and maxillary
lymph nodes distant to the application site (as control) were
analyzed for OPN mRNA expression using RT-PCR after
0, 6, 12, 24, and 48 h of TNCB application (Fig. 2, A–C).
12 h after TNCB painting, OPN mRNA was gradually
upregulated in hapten treated skin (Fig. 2 A), peaking at
48 h, in contrast to skin treated with the vehicle acetone
alone. In parallel, OPN mRNA was strongly upregulated
in axillary lymph nodes draining the skin (Fig. 2 B). In
contrast, maxillary lymph nodes distant to the site of hapten
application showed only a slight upregulation of OPN
mRNA (Fig. 2 C). When immunohistochemistry of skin
draining lymph nodes was performed with mAbs against
OPN (mAb 2.2 [37]), lymph nodes of untreated (Fig. 2 D)
or acetone painted mice (data not shown) showed little to
no OPN specific staining. After 24 h following TNCB ap-
plication, OPN staining was observed in draining lymph
nodes which strongly increased up to 48 h (Fig. 2 D). OPN
expression was predominantly located in the T cell areas of
these lymph nodes as detected by staining of serial lymph
node sections with anti-CD3 mAb (Fig. 2 D). No staining
was found in lymph nodes of hapten-treated OPN-defi-
cient mice (Fig. 2 D). These findings argue for an OPN
function in the sensitization phase of CHS.
OPN Induces Chemotactic DC Migration In Vitro. Hav-
ing demonstrated that OPN is expressed in skin and in
lymph nodes draining that skin site during the sensitization
phase of CHS we investigated whether OPN could func-
tion as a chemoattractant for murine LCs/DCs. Two puta-
tive OPN receptors CD44 and  v 3 are functionally in-
volved in OPN-mediated cell migration (22, 24). While
 v 3-mediated migration requires divalent cations, CD44-
mediated OPN effects are Ca2 /Mg2  independent (22, 23,
24). We used recombinant GST-OPN to assess DC migra-
tion toward OPN in microchamber migration assays in the
presence or absence of Ca2 /Mg2 . Addition of recombi-
nant GST-OPN to the lower chamber induced DC migra-
tion in a dose-dependent manner in both settings. How-
ever, in the presence of Ca2 /Mg2 , up to 30% more DCs
migrated toward OPN (Fig. 3). DCs migrated toward OPN
in a manner resembling chemotaxis rather than chemokine-
sis because increasing concentrations of OPN in the upper
chamber inhibited DC migration toward OPN (Table I).
These findings indicate that OPN stimulates DC migration
and that both Ca2 /Mg2 -dependent and -independent re-
ceptors are involved in DC migration toward OPN.
Expression of  v 3 Is Differentially Modulated during DC
Maturation. Our chemotaxis experiments indicated that
OPN-induced DC migration can be mediated by Ca2 /
Mg2 -dependent and -independent mechanisms. CD44 has
been characterized as a migration-mediating OPN receptor
acting in the absence of Ca2 /Mg2  (23). Having previ-
ously demonstrated the importance of CD44 for DC func-
Figure 1. LCs migrate to sites of high OPN expression to form cords
within the dermis. Cryosections of human skin cultured for 24 h were
stained with anti-OPN mAb 10A16 followed by secondary Cy3-conju-
gated F(ab), goat-anti–mouse IgG (H L) to detect OPN (red), and
FITC-conjugated anti-CD1a antibody (green). The dotted line marks the
dermo-epidermal junction. (A) CD1a  LCs within the Epidermis (green
**). CD1a  cells have migrated toward areas of high OPN expression (red
***) at the microvascular plexus of the papillary dermis. (B) Hemalum
stained serial section of the same specimen. (C) CD1a  cells (green) form
cords within the area of skin microvascular endothelial cells that highly
express OPN (red). (D) Hemalum stained serial section of the same spec-
imen. Same magnification in A, B, C, and D: bar 10  m.1223 Weiss et al.
tion during the sensitization phase of CHS (25) we now
investigated the expression of the Ca2 /Mg2 -dependent
OPN receptor  v 3 on DCs. DCs were generated from
bone marrow culture and analyzed by FACS® (DC purity
 80% by definition of high expression of Iab, CD11c,
B7–1, and B7–2 in FACS® analysis [30]). Immature DCs
from day 6 bone marrow-DC cultures expressed both
 v 3 (CD51/CD61; Fig. 4, A and B) and CD44 (Fig. 4
C). Upon maturation in bone marrow-DC cultures  v 3
expression was gradually upregulated from day 6 to 8
while CD44 was consistently expressed (Fig. 4, A–C).
Taken together these results support the notion that the
two OPN receptors  v 3 and CD44 are expressed on
murine DCs.
Figure 2. OPN is upregulated in skin and lymph nodes during CHS TNCB or acetone was applied to abdominal skin of C57BL/6 mice. Mice were
killed at the indicated time points and skin specimens (A) from the haptenized site and axillary lymph nodes draining this skin site (B) or distant maxillary
(C) lymph nodes were collected and subjected to RT-PCR with OPN specific primers as described in Materials and Methods. Percent relative intensity
of the OPN mRNA compared with  -actin control was calculated with E.A.S.Y.® Win32-software. (D) TNCB was applied to abdominal skin of
C57BL/6 mice. Immunohistochemical staining of cryosections with an antibody against OPN or CD3 of skin draining axillary lymph nodes from OPN
deficient ( / ) and wild-type ( / ) C57BL/6 mice at the indicated time points after TNCB application to the abdominal skin. Top row: upregulation
of OPN expression from 0 to 48 h. Bottom row left: higher magnification of OPN expression at 48 h. Bottom row middle: staining of skin draining ax-
illary lymph nodes from OPN-deficient ( / ) mouse with mAb against OPN. Bottom row right: staining with an antibody against CD3 of a serial sec-
tion of the lymph node specimen taken at 48 h after TNCB application (top row right), * T cell areas, ** B cell follicle. Magnification, bar 60  m, except
bottom left (48 h) bar 20  m. OPN was visualized with brown, CD3 with blue chromogen as described in Materials and Methods.1224 Osteopontin in DC Migration
Both Anti-CD44 and  v 3 mAbs Block OPN-induced DC
Migration. Having identified two putative OPN recep-
tors, CD44 and  v 3 on DCs, we next sought to deter-
mine their functional role for OPN-mediated DC migra-
tion. DCs were preincubated with mAbs against  v
(RMV7), anti-CD44 (IM7 or KM81), or appropriate con-
trol mAb. Chemotaxis-chamber experiments were then
performed in the presence or absence of divalent cations
(Fig. 5). In Ca2 /Mg2  free medium anti- v integrin mAb
did not affect DC migration toward OPN, while anti-
CD44 mAb IM7 (Fig. 5) and KM81 (data not shown) in-
hibited OPN-induced migration. In Ca2 /Mg2  contain-
ing medium, both anti- v integrin and anti-CD44 mAbs
blocked DC migration (Fig. 5). Combination of anti-
CD44 and  v mAbs resulted in a complete block of DC
migration toward OPN (Fig. 5). Spontaneous chemokine-
sis or LPS-induced DC migration were not affected by any
of the mAbs (data not shown).
Intradermal Injection of OPN Induces LC Migration from the
Epidermis. Analysis of LC emigration from epidermal
sheets is a well-defined system to study skin DC migration
in vivo (41). To confirm a functional role of OPN in LC/
DC migration in vivo, OPN or appropriate controls were
injected into the ear pinnae of mice. After 48 h ears were
Figure 3. DCs migrate toward OPN in a dose-dependent manner in
the presence or absence of divalent cations. Mouse DC (106 cells) were
placed into the upper chambers of modified Boyden chambers as de-
scribed in Materials and Methods. GST control protein (2  g/ml) or the
indicated concentrations of GST-OPN were added to the lower cham-
ber. Assays were performed in HBSS without Ca2 /Mg   (A) or with
Ca2 /Mg   (B). Data are shown as cells/mm2   SD of four chambers.
Figure 4.  v 3 expression is upregulated during DC maturation. Mu-
rine DCs were generated from bone marrow precursors, purified by den-
sity gradient as described in Materials and Methods, and stained for
FACS® analysis with mAbs against (A)  v (CD51), (B)  3 (CD61, mAb)
integrin, or (C) pan CD44 mAb. DC were harvested on days 6, 7, and 8
of DC culture.
Table I. OPN Induces Chemotactic DC Migration
Number of migrated cells
Upper chamber contents of ( g/ml)
Lower chamber
contents ( g/ml) HBSS 0.5 OPN 2.0 OPN
HBSS 155.5   4.95 178.0   58 171.5   17.7
0.5 OPN 239.0   39.6 140.0   8.5  
2.0 OPN 269.5   36.1   173.0   2.1
2.0 GST 97.5   12.0   
106 cells/ml DCs were generated as described in Materials and Methods
and applied to the upper chamber of modified Boyden chambers. The
chamber was incubated for 4 h at 37 C and cells that had migrated to
the lower chamber were evaluated as described in Materials an Methods.
Data are shown as cells/mm2   SD that had migrated across membranes
of triplicate chambers.1225 Weiss et al.
obtained and LCs within the epidermal sheets were identi-
fied by ATPase staining (34; Fig. 6 A). The number of LCs
remaining within the epidermis was quantified by micro-
scope. In OPN-injected ears, up to 50% of LC had left the
epidermis after 48 h (Fig. 6, A and B) indicating that OPN
strongly induced DC migration from the epidermis in vivo.
In accordance with the in vitro migration experiments this
effect could be partially blocked by mAbs against CD44
and  v (Fig. 6 C). While anti-CD44 mAb injected simulta-
neously with OPN almost completely blocked OPN stim-
ulated LC emigration from the skin, the anti- v antibody
had an inhibitory effect of up to 50%.
OPN Serves a Functional Role in LC-dependent Induction of
CHS. To finally test the role of OPN in vivo we investi-
gated the CHS response of mice lacking a functional OPN
gene (28). OPN-deficient C57BL/6 mice and wild-type
littermates were sensitized epicutaneously to the hapten
TNCB on day 0. Upon challenge with TNCB at the ear
on day 5, wild-type mice showed a normal ear swelling re-
sponse (Fig. 7). However, when the ears of TNCB sensi-
tized OPN-deficient littermates ( / ) were challenged
with the hapten, these mice had a significantly reduced ear
swelling response 24 and 48 h after challenge (Fig. 7).
Based on these findings we postulated that OPN is of key
importance for the capacity of LCs to induce a CHS re-
sponse against epicutaneously applied haptens.
To exclude that a reduced number of LCs within the skin
of OPN ( / ) mice was responsible for the impaired CHS
response, the number of LCs within the epidermis of OPN-
deficient mice was compared with wild-type littermates by
ATPase staining as described in Materials an Methods. No
differences in the number and morphology of epidermal
LCs was observed (data not shown), demonstrating a nor-
mal distribution of LCs in the skin of OPN-deficient mice.
We now addressed whether the reduced migration of
DCs is responsible for the altered CHS response by using
an established model to detect the number of LCs/DCs
that migrate from the skin to regional draining lymph
nodes during the sensitization phase of CHS (35). The hap-
ten FITC was applied to the skin of abdomen and thorax of
OPN /  and OPN /  mice and the number of FITC/
CD11c double-positive cells that had entered the lymph
node 48 h after hapten application was analyzed (35). In
OPN /  mice we found a strongly reduced number of
CD11c /FITC  cells in the skin draining lymph nodes
compared with OPN /  littermates (Fig. 8 A).
To further underline the role of OPN in the migration
of DCs to lymph nodes a second model was used (30). DCs
were generated from wild-type ( / ) littermates of OPN
mutant mice ( / ) were fluorescently labeled with PKH-2
and injected into the abdominal skin of wild-type and
OPN-deficient mice. Interestingly, up to 75% less wild-
Figure 5. OPN-induced migration of DCs is dependent on CD44 and
the  v integrin subunit on DCs. 106 untreated murine DCs or DCs pre-
treated with 10  g/ml of control antibody (Y13–259), anti-CD44 mAbs
(IM7), or anti- v mAb (RMV7) were added to the upper chamber of
modified Boyden chambers in the presence or absence of Ca2 /Mg2 . In
all assays DCs migrated for 4 h at 37 C. Data is shown as cells/mm2   SD
of four chambers.
Figure 6. OPN induces emigration of LCs from the epidermis which is
partially inhibited by mAbs against CD44 and  v. Groups of three mice
were left untreated or injected with either PBS, GST control protein (50
 g/ml), or GST-OPN (50  g/ml in PBS) into the pinnae of ears (A and
B). In panel A epidermal sheets were stained by ATPase histochemistry as
described in Materials and Methods. Within the epidermis ATPase is spe-
cifically expressed by LCs, stained dendritic LCs appear dark brown (bar
18  m). For mAb blocking experiments, anti-CD44 mAb (IM7),  v
(RMV7), or isotype-matched control antibodies (all 10  g/ml) were
added to the volume injected (C). Ears were removed after 48 h, epider-
mal sheets were prepared and stained for ATPase expression, and LC/
mm2 were counted by microscope as described in Materials and Methods.
*    statistically significant at P    0.05, one way analysis of variance
(ANOVA), Student-Newmann-Keuls test of four ears. Percent induction
was calculated by defining the number of LCs in untreated ears as 0%.1226 Osteopontin in DC Migration
type DCs entered the axillary and inguinal lymph nodes
when injected into the OPN-deficient ( / ) animals (Fig.
8, B and C). These findings indicate that OPN is of func-
tional importance for the attraction of DC to enter into re-
gional lymph nodes, and therefore plays a key role in the
induction of CHS.
Discussion
In the present work we focused on the function of OPN
during the sensitization phase of CHS which crucially de-
pends upon the migration of hapten-carrying LCs/DCs
from the epidermis via lymphatic vessels to regional drain-
ing lymph nodes. Here we demonstrate that OPN is an im-
portant chemotactic factor for DC that guides LCs/DCs
from the periphery to regional lymphatic organs.
OPN is a migration inducing factor in several cell sys-
tems, e.g., endothelial cells, smooth muscle cells, fibroblasts,
lymphocytes, and macrophages (14, 21, 22, 42). In inflam-
matory responses, invading macrophages are attracted to
sites of high OPN expression, i.e., in tubulointerstitial
nephrotic disease, myocardial infarction, and response to
bacterial infection or skin wounds (11, 28, 38, 43). We
found that LCs migrating from the epidermis predominantly
traffic toward the highly OPN expressing area of the papil-
lary microvascular dermal plexus. In OPN-rich areas LCs
line up to form the characteristic cord-like structures within
lymphatics. Furthermore, after the application of the contact
allergen TNCB on murine skin we found that OPN
mRNA is upregulated in the skin as well as in lymph nodes
draining the skin beginning as early as 12 h after treatment.
Based on our finding that OPN is upregulated in tissues
traversed by DCs, we investigated the role of OPN in DC
trafficking. We found that OPN induces chemotactic DC
migration in microchamber assays. Most significantly, in
vivo LC emigration from the epidermis was initiated by in-
Figure 7. OPN-deficient mice have a reduced CHS-response to TNCB. In OPN null mutant mice and wild-type litter mates CHS was induced as
described in Materials and Methods. *Statistically significant reduction of ear swelling at P   0.001 (one way ANOVA, Dunnett’s test). Each bar repre-
sents mean ear swelling data pooled from four animals measured 24 and 48 h after challenge. Representative of three independent experiments is shown.
Figure 8. OPN mutant mice
have a reduced capacity to attract
DCs into lymph nodes draining
the skin. (A) Change in the
number of CD11c /FITC 
DCs in lymph nodes analyzed
48 h after painting of 2 mg FITC
dissolved in a 50:50 (vol/vol)
acetone dibutylphtalate (BDH)
mixture on the skin of thorax
and abdomen of OPN wild-type
( / ) or OPN mutant mice
( / ). Lymph node single cell
suspensions were prepared from
pooled axillary and inguinal
lymph nodes and the number of
CD11c /FITC  cells within the
lymph nodes was evaluated by
FACS® analysis, as described in
Materials and Methods. One dot
represents the number of
CD11c /FITC  cells in pooled
axillary and inguinal lymph
nodes of one mouse. Bars indicate the mean   SEM of seven mice. The difference in the two groups was statistically significant (paired t test, P   0,005).
A representative of three independent experiments is shown. (B) PKH-2 labeled wild-type ( / ) DCs were injected into the abdominal skin of wild-
type ( / ) or OPN mutant mice ( / ). After 20 h axillary and inguinal lymph node cells from one animal each were pooled, stained for CD11c, and
the total number of PKH-2–positive DCs was analyzed by FACS® as described in Materials and Methods. *Statistically significant reduction of PKH-2–
positive DCs in LNs of OPN /  mice compared with DCs in LN of  /  mice (P   0.03 one way ANOVA, Student-Newmann-Keuls test). Each bar
represents the mean   SEM from three independent experiments. (C) FACS® analysis of PKH-2 (FL-1) positive cells in pooled axillary and inguinal
lymph nodes from one mouse 20 h after injection of PKH-2–positive DCs into abdominal skin. Bars represent percent of PKH-2  measured lymph node
cells. A representative of three independent experiments is shown.1227 Weiss et al.
tradermal OPN injection. These findings strongly argue
that upregulation of OPN in sensitized skin is relevant in
guiding DCs into the dermis on their path to draining
lymph nodes. Several OPN producing cell types are lo-
cated within the dermis. Dermal fibroblasts, lymphocytes,
macrophages, and vascular and lymphatic endothelial cells
(44) could all produce OPN after antigenic challenge, lead-
ing to chemokine-like attraction of DCs. Here we found
that OPN is especially expressed in the vicinity of papillary
plexus endothelial cells. Due to a lack of available specific
markers for lymphatic endothelial cells we cannot yet de-
termine whether OPN is secreted both by microvascular
endothelial cells and by the lymphatic endothelium. How-
ever, secretion of chemotactic OPN by microvascular en-
dothelial cells could also lead to an attraction of DCs
toward the lymphatics, which closely accompany the capil-
laries of the microcvascular plexus. By now we can only
speculate which factors could be involved in the upregula-
tion of OPN within the skin during the sensitization phase
of CHS. Two possible candidates secreted upon hapten
challenge of the skin are TNF- , secreted by keratinocytes
and IL-1 , secreted by LCs. Both provide important signals
in the LC migration from the epidermis (45).
In CHS another potential source of OPN production are
cells within draining lymph nodes (10). Beginning at 12 h
after sensitization we found that OPN mRNA is upregu-
lated in lymph nodes draining the skin and OPN protein
expression is upregulated in the T cell areas of draining
lymph nodes. Here activated T cells and macrophages are
prime candidates for OPN production (17, 46). We specu-
lated that OPN produced by lymph node cells could attract
DCs to migrate to these sites. We therefore would like to
propose a model in which OPN secreted in lymph nodes,
e.g., by activated T cells could attract DCs to lymph nodes.
Different OPN functions might be responsible for the
chemoattractive OPN effect on DCs in vivo. The injected
OPN may form soluble gradients within the tissue, thereby
attracting the DCs to traffic toward OPN. Furthermore, in
vitro it has been shown that as an ECM component, OPN
interacts with collagen I, II, III, and IV (18, 19) and fi-
bronectin (18, 20). One may speculate that also in vivo
ECM-bound OPN could form a gradient-like path to
guide DCs through tissues.
Having identified a chemotactic function of OPN in DC
migration we investigated OPN receptors on DCs mediat-
ing this function. Two OPN receptors,  v 3 and CD44
have been especially associated with OPN-induced cell mi-
gration (21, 23, 24, 39). Here we characterized the expres-
sion of  v 3 on DCs and found that DCs upregulate both
the  v and  3 integrin subunits upon maturation in bone
marrow cultures, while CD44 was constitutively expressed.
By modulating divalent cation concentrations in the pres-
ence or absence of blocking  v and CD44 mAbs we found
that both  v integrin and CD44 are functionally involved
in OPN-induced DC migration in microchamber migra-
tion assays. These findings are relevant for DC migration in
vivo. Applying LC migration assays in murine ear sheets
(41), anti- v and anti-CD44 mAb (recognizing the stan-
dard epitope of CD44) partially blocked LC emigration
from the epidermis. We cannot exclude that other OPN
binding integrins, i.e.,  v 1,  v 5 are involved in OPN-
mediated DC migration. However, it was previously dem-
onstrated that migration of human smooth muscle cells de-
pends on  v 3, but not on the OPN binding integrins
 v 1 and  v 5 (22).
We previously investigated the expression and function
of CD44 splice variants on LCs/DCs (25) and demon-
strated that LCs/DCs constitutively express the standard
epitope of CD44 (CD44s, pan CD44, common to all
CD44 expressing cells) and epitopes formed jointly by
CD44v7/8. Upon activation CD44 epitopes encoded by
exons v4, v5, v6, and v9 are upregulated on LCs/DCs.
These epitopes are especially involved in the migration of
these cells from the epidermis, their adhesion in lymph
nodes, and the induction of CHS (25). The data shown
here support the notion that CD44 is involved in mediat-
ing the migration-inducing effects of OPN, as OPN-
induced DC migration in Boyden chambers and LC mi-
gration from the skin could be blocked by mAbs IM7 and
KM81 directed against the standard epitope of CD44
(CD44s, panCD44) (25). Based on our data we cannot tell
at present to what extent different CD44 variant isoforms
are involved in LC/DC interactions with OPN. However,
in Boyden chamber migration assays mAbs against CD44v4
(9A4) or v6 (10D1) (25) were without effect on OPN me-
diated DC migration (data not shown). This does not rule
out that CD44 variant encoded isoforms are involved in
DC migration. However, it indicates that the antibodies
IM7 and KM81 recognize a CD44 epitope essential for
OPN activity. Our work is in accordance with the results
of Weber et al. who demonstrated that the anti-CD44
mAb KM81 inhibited OPN-induced migration of CD44-
transfected A31 murine fibroblasts (transfected with a
cDNA containing exons v7 through v10) and the CD44-
expressing T cell hybridoma AF3.G7 (which likely express
a CD44 variant of  115kD) (23, 47). Furthermore, other
studies demonstrated that CD44 variants cooperate with
 1-containing integrins to bind to OPN to stimulate che-
motaxis of tumor cells (24). Based on these studies and the
work presented here it remains to be defined exactly which
CD44 isoforms are able to interact with OPN on DCs and
whether other molecules such as  1 integrin are involved.
Recently it was demonstrated that CD44-hIg fusion pro-
teins did not bind to different forms of human OPN (48).
These findings are in contrast to other reports that demon-
strated binding of OPN to CD44 expressed in murine fi-
broblast cell lines and T cell hybridomas (23). In this study
we did not investigate OPN binding interactions with
CD44 on LCs/DCs. However, we clearly demonstrate that
OPN-induced migration is blocked by two different mAbs
against CD44s (IM7 and KM81). To what extent the  1-
integrin subunit is involved in this mechanism must be the
subject of further investigation.
The ultimate test for the role of OPN in CHS is to ex-
amine the ability of OPN-deficient mice to mount an ap-
propriate CHS response to an epicutaneously applied hap-1228 Osteopontin in DC Migration
ten. Indeed we found that OPN null mutant mice had a
significantly reduced CHS response to TNCB. These find-
ings complement previous studies with OPN mutant mice
that have demonstrated a severely impaired cell-mediated
immunity to viral and bacterial infections and a reduced de-
velopment of sarcoid type granulomas (16, 17). This test,
however, does not yet demonstrate that the impaired cell-
mediated immune response is due to a reduced migration of
LCs/DCs. Having excluded that OPN-deficient mice have
a reduced number of LCs in the epidermis we used two dif-
ferent established approaches to further prove this concept
(30, 35). When FITC was painted on abdominal skin, we
found significantly less FITC /CD11c  cells within the
draining lymph nodes of OPN-deficient mice 48 h after
FITC application. Furthermore, when we injected wild-
type DCs into OPN-deficient mice up to 75% less DCs
were attracted into lymph nodes of OPN-deficient mice.
These experiments clearly demonstrates an impaired migra-
tory function of DCs in the absence of OPN. However, we
cannot exclude that other OPN functions responsible for
the migration of T cells or macrophages into inflammatory
sites are additionally affecting the reduced CHS ear swelling
response in OPN mutant mice after hapten challenge.
In summary, our findings provide evidence that OPN
upregulated in the skin and draining lymph nodes during
the sensitization phase of CHS is a chemotactic protein for
LCs/DCs. Pro-migratory OPN effects on DCs are medi-
ated by at least two OPN receptors, CD44 and an  v-con-
taining integrin. Interestingly, mice deficient in OPN pro-
duction have a reduced CHS response. This effect is likely
to be due to a reduced migratory capacity of DCs in OPN
mutant mice. Our data indicates that OPN function in di-
rected migration of DCs from the periphery to regional
lymph nodes is an important event in DC-mediated de-
layed type hypersensitivity.
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